Differential involvement of p38 and JNK map kinases in HIV-1 Tat and gp120-induced apoptosis and neurite degeeration in striatal neurons

被引:58
作者
Singh, IN
El-Hage, N
Campbell, ME
Lutz, SE
Knapp, PE
Nath, A
Hauser, KF
机构
[1] Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY 40536 USA
[2] Univ Kentucky, Med Ctr, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA
[3] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA
关键词
caspase-3; neurotoxicity; AIDS; neurodegeneration; basal ganglia;
D O I
10.1016/j.neuroscience.2005.05.028
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The role of p38 and c-jun-N-terminal kinases 1/2, members of the mitogen-activated protein kinase family, in mediating the toxic effects of human immunodeficiency virus-1 transactivator of transcription (Tat) and gp120 were explored in primary mouse striatal neurons in vitro. Both Tat and gp120 caused significant increases in p38 and c-jun-N-terminal kinase mitogen-activated protein kinase phosphorylation, caspase-3 activity, neurite losses and cell death in striatal neurons. Tat-induced increases in caspase-3 activity were significantly attenuated by an inhibitor of c-jun-N-terminal kinase (anthra[1,9-cd]pyrazol-6(2H)-one), but not by an inhibitor of p38 ([4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1 H-imidazole]), mitogen-activated protein kinase. However, despite preventing increases in caspase-3 activity, c-jun-N-terminal kinase inhibition failed to avert Tat-induced neuronal losses suggesting that the reductions in caspase-3 activity were insufficient to prevent cell death caused by Tat. Alternatively, gp120-induced increases in caspase-3 activity, neurite losses and neuronal death were prevented by p38, but not c-jun-N-terminal kinase, mitogen-activated protein kinase inhibition. Our findings suggest that gp120 induces neuronal dysfunction and death through actions at p38 mitogen-activated protein kinase, while Tat kills neurons through actions that are independent of p38 or c-jun-N-terminal kinase mitogen-activated protein kinase, or through the concurrent activation of multiple proapoptotic pathways. (c) 2005 Published by Elsevier Ltd on behalf of IBRO.
引用
收藏
页码:781 / 790
页数:10
相关论文
共 68 条
  • [1] BRAIN VIRAL BURDEN IN HIV-INFECTION
    ACHIM, CL
    WANG, R
    MINERS, DK
    WILEY, CA
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1994, 53 (03) : 284 - 294
  • [2] AVISON M, 2003, CLIN NEUROVIROLOGY, P251
  • [3] Neuroimaging correlates of HIV-associated BBB compromise
    Avison, MJ
    Nath, A
    Greene-Avison, R
    Schmitt, FA
    Greenberg, RN
    Berger, JR
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2004, 157 (1-2) : 140 - 146
  • [4] Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum
    Bansal, AK
    Mactutus, CF
    Nath, A
    Maragos, W
    Hauser, KF
    Booze, RM
    [J]. BRAIN RESEARCH, 2000, 879 (1-2) : 42 - 49
  • [5] Dysregulation of mitogen-activated protein kinase signaling pathways in simian immunodeficiency virus encephalitis
    Barber, SA
    Uhrlaub, JL
    DeWitt, JB
    Tarwater, PM
    Zink, MC
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (02) : 355 - 362
  • [6] HIV dementia and the basal ganglia
    Berger, JR
    Nath, A
    [J]. INTERVIROLOGY, 1997, 40 (2-3) : 122 - 131
  • [7] Bhat NR, 1998, J NEUROSCI, V18, P1633
  • [8] Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced by cell membrane-associated human immunodeficiency virus type 1 envelope glycoprotein (gp120)
    Biard-Piechaczyk, M
    Robert-Hebmann, V
    Richard, V
    Roland, J
    Hipskind, RA
    Devaux, C
    [J]. VIROLOGY, 2000, 268 (02) : 329 - 344
  • [9] CD4 dependence of gp120IIIB-CXCR4 interaction is cell-type specific
    Bodner, A
    Toth, PT
    Oh, SB
    Lu, ML
    Tran, PB
    Chin, RK
    Ren, DJ
    Miller, RJ
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2003, 140 (1-2) : 1 - 12
  • [10] Mixed lineage kinase 3 mediates gp120IIIB-induced neurotoxicity
    Bodner, A
    Maroney, AC
    Finn, JP
    Ghadge, G
    Roos, R
    Miller, RJ
    [J]. JOURNAL OF NEUROCHEMISTRY, 2002, 82 (06) : 1424 - 1434